OTC Healthcare in Nigeria
Euromonitor International's OTC Healthcare in Nigeria market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 13 | Publication date: May 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Trend towards self-medication drives the positive development of OTC healthcare in Nigeria
The OTC healthcare market is the biggest and most vibrant market for medical products in Nigeria. OTC healthcare current value sales grew by a total of 84% over the 2000-2005 review period. Current value growth was mainly attributable to a rise in self-medication among the majority of Nigerian consumers, which was in turn attributable to the high cost and other problems associated with visiting a doctor in the country. At the end of the review period, OTC healthcare also benefited from improved regulatory activities by the National Agency for Food and Drug Administration and Control (NAFDAC). Government policies and spending on healthcare also impacted positively on OTC healthcare current value sales, as did advertising and marketing activities by leading players.
Systemic analgesics benefits from high demand among consumers in low income groups
Systemic analgesics was the largest value sales contributor within OTC healthcare in Nigeria in 2005, accounting for a market value share of 20%. There is a high level of demand for analgesics products in Nigeria, particularly among consumers in low income groups, who make up the bulk of the population. Consumers in low income groups generally work at menial or physically demanding jobs such as street hawking, and frequently use analgesics products to treat work-related aches and pains. The Paracetamol BP brand is especially popular with low-income group consumers. Age-related complaints such as arthritis and rheumatism also drive demand for analgesic products in Nigeria, as most people cannot afford professional medical treatment for these conditions and thus prefer to self-medicate.
Multivitamins is most dynamic in 2005 thanks to the rise of preventative self-medication
Multivitamins showed the most dynamic performance within OTC healthcare in 2005 to record impressive growth of 16% in current value sales. It was also the most dynamic performer in terms of current value growth for the review period as a whole. During the review period, vitamins and dietary supplements products in general benefited from wider distribution in grocery outlets and healthfood shops outlets, as well as from rising health concerns among Nigerian consumers. Given the high cost of professional medical treatment in the country, many Nigerian consumers try to prevent disease from occurring in the first place by consuming vitamins and dietary supplements products.
NAFDAC meets with some success in the war against counterfeit drugs
At the beginning of the review period, the National Agency for Food and Drug Administration and Control (NAFDAC) struggled to deal with the problem of counterfeit drugs in Nigeria, meeting with little success. In 2001 however NAFDAC appointed a new director general, who sought to improve the situation with a review of the organisation's policies. This soon proved effective, and official statistics released at the end of the review period showed that NAFDAC reduced the incidence of counterfeit drugs in the country by about 40% between 2001 and 2005.
Ageing population and rising health awareness will boost OTC healthcare over 2005-2010
OTC healthcare sales are expected to grow at a constant value CAGR of 2% over the forecast period to reach NGN16.6 billion in 2010. Constant value growth will be stimulated by an expected increase in government spending on healthcare, advertising activities by OTC healthcare companies and heightened competition among key players. The ageing population and increasing health awareness among Nigerian consumers generally are likely to be particularly influential in driving constant value sales of analgesics and vitamins products.
Table of contents
OTC HEALTHCARE IN NIGERIA : MARKET INSIGHT
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.4 Leading Company Profiles: GlaxoSmithKline Nigeria Plc
Summary 1 GlaxoSmithKline Nigeria Plc: Operational Indicators 2004
3.5 Leading Company Profiles: May & Baker Nigeria Plc
Summary 2 May & Baker Nigeria Plc: Operational Indicators 2004
3.6 New Product Developments
Summary 3 OTC Healthchare: New Product Launches 2005
3.7 Retail Distribution
Table 7 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.8 Retailer Activity and Private Label Trends
3.9 Forecast Market Performance
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 10 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. DEFINITIONS